Mental Health Resource Guide: TMS Arkansas

If you’re experiencing depression, you’re not alone! 17.3 million1 people worldwide suffer from depression, and it’s a leading cause of disability2 worldwide.

NeuroStar Advanced Therapy is a noninvasive, non-drug treatment for depression and is free from side effects often associated with antidepressant medications. It’s best for people who have not benefited from prior medication and would like to try a non-systemic treatment. Transcranial Magnetic Stimulation (TMS) is a medical procedure that works by delivering highly focused MRI-strength magnetic pulses to noninvasively (without surgery) stimulate the brain and treat major depression. NeuroStar has delivered 83% positive response and 62% remission3 in patients suffering with depression.

TMS Arkansas, Dr. Leslie Smith, M.D. and his experienced staff, are excited to offer this significantly effective treatment to the community and their patients. Call us today to set up a consultation to begin achieving full remission of your symptoms.

Evaluating depression in patients is important because some patients may not realize they are suffering with depression, and those who already have the diagnosis might not know how severe it is. The best way to learn more about your depression is to take a personal screening survey to determine your level of depression whether it is severe, moderate, mild or not depressed. Knowing that information can help you form a treatment program with your health care provider team.

The Patient Health Questionnaire (PHQ-9) is a standard depression screening tool. It’s quick and easy to fill out and can give you an objective look at how you’re feeling and the severity of your symptoms. We encourage you to take the survey and contact our office to discuss your results. We are here to help if you or a loved one are suffering with depression at any level of severity. Please call us if you’d like to learn more about it and if you are eligible – we offer free consultations at your convenience.

Visit for safety information and indications for use.

2. World Health Organization Depression Fact Sheet
3. Sackeim HA, et al. (2020) J. Affect. Disord. 277:65-74. Based on a real-world, retrospective study using CGI-S and a sample size of 615 patients.

700 S. Schiller, Ste. 300
Little Rock

Related Articles